Today, biomaterial-based solutions play an important role in clinical applications.
They can be implemented e.g. astissue repair scaffolds or replace elements of damaged body parts. As these biomaterials directly interact with the human body, unforseen adverse reactions can occur.
PANBioRA will develop a tool to better assess a patient-specific immune reaction to biomaterials and thus allow improved clinical outcomes.
Due to a signifcant rise of coronavirus infections in Portugal the Organising Committee of ESB 2021 (5-9 September 2021) has taken the decision to move it to a fully virtual format.
Online article on PANBioRA available in EU Research Journal's summer edition!
PANBioRA's 7th press release gives an outlook on next activities in this last project year
A hybrid event conference on science, technology and translation
International Team for Implantology World Symposium 2021 held virtually
The 31st Conference of the European Society for Biomaterials will be held virtually from September 5-9 2021.